Consolidated Statements of Operations (USD $) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
EXPENSES
Research and development	$ 403,413		$ 403,413
General and administrative	261,632	514,041	873,477	1,138,715
Impairment of intangible assets		1,935,621	0	1,935,621
Warrants, options and stock compensation	141,315	2,279,552	291,200	3,595,700
Fair value of common stock exchanged for warrants and notes payable	2,706,105	3,069,792	2,706,105	3,069,792
Legal and professional services	384,604	290,603	516,290	433,706
Depreciation and amortization	610,515	7,481	1,088,619	16,168
TOTAL EXPENSES	4,507,584	8,097,090	5,879,104	10,189,702
LOSS FROM OPERATIONS	(4,507,584)	(8,097,090)	(5,879,104)	(10,189,702)
OTHER (INCOME)/EXPENSES
(Gain) on adjustments to fair value of derivative liability		(9,216,927)		(8,980,077)
(Gain) on extinguishment of derivative liability		(1,409,530)		(1,409,530)
Other (income) expenses	(188,936)	17,636	(238,575)	15,072
Interest expense	136,584	35,084	194,878	58,055
TOTAL OTHER INCOME	(52,352)	(10,573,737)	(43,697)	(10,316,480)
NET (LOSS) INCOME FROM CONTINUING OPERATIONS	(4,455,232)	2,476,647	(5,835,407)	126,778
Net loss from discontinued operations		(129,157)		(256,068)
NET (LOSS) INCOME	(4,455,232)	2,347,490	(5,835,407)	(129,290)
Preferred dividends		47,250		171,625
NET (LOSS) INCOME ATTRIBUTABLE TO HOLDERS OF RESTORGENEX COMMON STOCK	$ (4,455,232)	$ 2,300,240	$ (5,835,407)	$ (300,915)
Basic and diluted (loss) income per share for continuing operations (in dollars per share)	$ (0.35)	$ 0.87	$ (0.62)	$ 0.07
Basic and diluted loss per share for discontinued operations (in dollars per share)		$ (0.05)		$ (0.14)
TOTAL BASIC AND DILUTED (LOSS) INCOME PER SHARE (in dollars per share)	$ (0.35)	$ 0.82	$ (0.62)	$ (0.07)
BASIC WEIGHTED AVERAGE SHARES OUTSTANDING	12,867,845	2,862,264	9,483,395	1,885,485
FULLY-DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING	12,867,845	2,862,264	9,483,395	1,885,485